<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        123-186-00
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2000
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        RANTAG 50MG AMP.
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        RANITIDINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        25
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg/ml
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution for injection
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        2
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Ampoule
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        19.65
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Gulf Pharmaceutical Industries (Julphar)" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Gulf Pharmaceutical Industries (Julphar)
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A02BA02
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Rantag</strong> contains a medicine called ranitidine. This belongs to a group of medicines called H2-receptor antagonists. It lowers the amount of acid in your stomach.</p><p><strong><u>For adults (including the elderly) Rantag is used to: </u></strong></p><p>- Heal and stop ulcers in the stomach, or the part of the gut it empties into (the duodenum)</p><p>- Stop ulcers from bleeding</p><p>- Improve problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as &lsquo;indigestion&rsquo;, &lsquo;dyspepsia&rsquo; or &lsquo;heartburn&rsquo;</p><p>- Stop acid coming up from the stomach while under anaesthetic during an operation.</p><p><strong><u>For children (6 months to 18 years) Rantag is used to: </u></strong></p><p>- Heal ulcers in the stomach, or the part of the gut it empties into (the duodenum)</p><p>- Heal and stop problems caused by acid in the food pipe (oesophagus) or too much acid in the stomach. Both of these can cause pain or discomfort sometimes known as &ldquo;indigestion&rdquo;, &ldquo;dyspepsia&rdquo; or &ldquo;heartburn&rdquo;.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not have Rantag if: </strong></p><p>- You are allergic to ranitidine or any of the other ingredients of this medicine (listed in Section 6).</p><p>If you are not sure, talk to your doctor or pharmacist before having <strong>Rantag</strong>.</p><p><strong>Warnings and precautions </strong></p><p>Check with your doctor or pharmacist before having your medicine if:</p><p>- You have stomach cancer</p><p>- You have kidney problems. You will need to have a different amount of <strong>Rantag</strong></p><p>- You have had stomach ulcers before</p><p>- You have a history of heart trouble</p><p>- You have a rare condition called acute porphyria</p><p>- You are over 65 years old</p><p>- You have lung disease</p><p>- You are diabetic</p><p>- You have any problems with your immune system.</p><p>If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before having this medicine.</p><p><strong>Other medicines and Rantag </strong></p><p>Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because <strong>Rantag</strong> can affect the way some other medicines work. Also some other medicines can affect the way <strong>Rantag</strong> works.</p><p>In particular tell your doctor or pharmacist if you are taking any of the following medicines:</p><p>- Lidocaine, a local anaesthetic</p><p>- Propranolol, procainamide or n-acetylprocainamide, for heart problems</p><p>- Diazepam, for worry or anxiety problems</p><p>- Phenytoin, for epilepsy</p><p>- Theophylline, for breathing problems (asthma)</p><p>- Warfarin, for thinning your blood</p><p>- Glipizide, for lowering blood glucose</p><p>- Atazanavir or delaviridine, for treating HIV infection</p><p>- Triazolam, for insomnia</p><p>- Gefitnib, for lung cancer</p><p>- Ketoconazole, an anti-fungal medicine, sometimes used for treating thrush.</p><p>Midazolam is a medicine that may be given to you just before you have an operation. Tell the doctor you are taking <strong>Rantag</strong> before your operation in case he or she wants to give you midazolam.</p><p>If you are not sure if any of the above applies to you, talk to your doctor, pharmacist or nurse before having <strong>Rantag</strong>.</p><p><strong>Pregnancy and breast-feeding </strong></p><p>If you are pregnant, might become pregnant or are breast-feeding, you should not use this medicine unless your doctor&rsquo;s advises it is essential.</p><p>Ask your doctor, pharmacist or nurse for advice before taking any medicine, if you are pregnant or breast-feeding.</p><p><strong>Important information of some ingredient if Rantag</strong></p><p><strong>Rantag</strong> injection contains sodium and is therefore essentially sodium-free.</p><p><strong>Rantag</strong> Injection contains potassium and is therefore essentially potassium-free</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You will never be expected to give yourself this medicine. It will always be given to you by a person who is trained to do so.</p><p><strong>Having this medicine </strong></p><p><strong>Rantag</strong> Injection will be given to you either:</p><p>- As a single injection into a muscle</p><p>- As a slow infusion into a vein. This is where the drug is slowly given to you over a few minutes</p><p>- As a continuous infusion into a vein. This is where the drug is slowly given to you over a few hours.</p><p>The usual dose for an adult (including the elderly) and adolescents (12 years and older) is 50 mg every 6 to 8 hours, as a single injection into a muscle.</p><p>Different doses may also be given to you as a slow infusion or continuous infusion, depending on what condition you are being treated for.</p><p>Children and infants (6 months to 11 years):</p><p>Your doctor will give <strong>Rantag</strong> by a slow injection into a vein. The maximum dose is 50 mg every 6 or 8 hours. It is usually only given while your child is unable to take <strong>Rantag</strong> by mouth.</p><p><strong>If you are given more Rantag than you should </strong></p><p>Your doctor or nurse will give you <strong>Rantag</strong> Injection so it is unlikely that you will receive too much. If you think you have been given too much or have missed a dose, tell your doctor or nurse.</p><p><strong>If you have any further questions on the use of this product, ask your doctor or pharmacist.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, this medicine can cause side effects, although not everybody gets them.</p><p>The following side effects may happen with this medicine.</p><p><strong>Stop taking Rantag and see a doctor straight away, if you notice any of the following serious side effects, you may need urgent medical treatment: </strong></p><p>- Allergic reactions, the signs may include:</p><p>&middot; Rash, itching or hives on the skin &nbsp;</p><p>&middot; Swelling of your face, lips, tongue or other parts of the body</p><p>&middot; Chest pain, shortness of breath, wheezing or having trouble breathing</p><p>&middot; Unexplained fever and feeling faint, especially when standing up</p><p>- Kidney problems, which can lead to back pain, fever, pain when passing urine, blood in the urine and changes in blood tests</p><p>- Severe stomach pain, this may be a sign of something called &lsquo;pancreatitis&rsquo;</p><p>- A slow or irregular heartbeat</p><p>Check with your doctor <strong>at your next visit </strong>if you notice any of the following:</p><p><strong>Uncommon </strong>(may affect up to 1 in 100 people)</p><p>- Stomach pain</p><p>- Constipation</p><p>- Feeling sick (nausea)</p><p><strong>Rare </strong>(may affect up to 1 in 1,000 people)</p><p>- Skin rash</p><p><strong>Rare side effects that may show up in blood tests: </strong></p><p>- Increase of serum creatinine in the blood (kidney function test)</p><p>- Changes to liver function</p><p>Check with your doctor <strong>as soon as possible </strong>if you notice any of the following:</p><p><strong>Very rare </strong>(may affect up to 1 in 10,000 people)</p><p>- There can be changes in the level of certain substances in your blood. This can lead to you feeling unusually tired or short of breath and being more likely to bruise or get an infection</p><p>- Feeling depressed, confused, seeing or hearing unexplained things (hallucinations)</p><p>- Headache (sometimes severe)</p><p>- Feeling dizzy or having blurred vision</p><p>- Your joints or muscles are painful or swollen or you cannot control their movement</p><p>- Your small blood vessels can become swollen (known as &lsquo;vasculitis&rsquo;). Signs of this can include: a rash, swollen joints or kidney problems</p><p>- Your liver can become swollen. This can lead to: nausea (feeling sick) or vomiting (being sick), loss of appetite or generally feeling unwell, itching, fever, yellowing of the skin and eyes or dark coloured urine</p><p>- Flushing or marks on your skin that look like targets</p><p>- Unexplained hair loss</p><p>- Diarrhoea</p><p>- Impotence</p><p>- Breast tenderness and/or breast enlargement</p><p>- Breast discharge</p><p>- awareness of the heart beat and/or increased heart rate</p><p>Not known (frequency cannot be estimated from the available data)</p><p>- shortness of breath</p><p><strong>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.</strong></p><p><strong>&nbsp;</strong></p><p><strong>To report any side effect(s):</strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax: </strong>+966-11-205-7662</p><p><strong>Call NPC at </strong>+966-11-2038222<strong>, Exts: </strong>2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone: </strong>8002490000</p><p><strong>E-mail: </strong>npc.drug@sfda.gov.sa</p><p><strong>Website: </strong>www.sfda.gov.sa/npc</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp; Keep out of the reach and sight of children.</p><p>-&nbsp; Do not use <strong>Rantag</strong> after the expiry date which is stated on the carton and inner vial label.</p><p>-&nbsp; Store below 30&deg;C. Protect from light and heat.</p><p>-&nbsp; Do not use <strong>Rantag</strong> if you notice any visible sign of deterioration.</p><p>-&nbsp; Medicines should<em> </em>not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is ranitidine. Each ampoule (2mL) contains 50mg of ranitidine &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(as Hydrochloride).</p><p>The other ingredients: Sodium phosphate dibasic, potassium phosphate monobasic, phenol, and water for injection.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Rantag ampoules are available in packs of 5 or 50 ampoules of 2mL.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Gulf Pharmaceutical Industries &quot; Julphar&quot;.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                09/03/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يحتوي <strong>رانتاج</strong> على مادة دوائية تعرف باسم رانيتيدين. والتي تنتمي إلى مجموعة من الأدوية تعرف باسم مضاد لمستقبلات الهستامين (هـ <sub>2</sub>)، تعمل هذه المادة على خفض كمية الحمض في المعدة.</p><p><strong><u>يستعمل رانتاج للبالغين (بما في ذلك فئة كبار السن) في الحالات التالية:</u></strong></p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من حدوث قرحات المعدة، أو قرحات الأمعاء (الإثنى عشر)</p><p>-&nbsp;&nbsp;&nbsp; إيقاف نزيف القرحات</p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من المشاكل الناتجة عن وجود الحمض في المريء أو فرط كمية الحمض في المعدة. كلاً من هذه الأسباب تسبب الشعور بالألم أو عدم الشعور بالراحة أحياناً يعرف &quot;بعسر الهضم&quot; أو &quot;حرقة المعدة&quot;</p><p>-&nbsp;&nbsp;&nbsp; منع ارتجاع الحمض من المعدة عندما يكون المريض تحت تأثير المخدر أثناء العمليات الجراحية</p><p><strong><u>يستعمل رانتاج للأطفال (بعمر </u></strong><strong><u>6</u></strong><strong><u> </u></strong><strong><u>شهور </u></strong><strong><u>إلى 18 سنة) في:</u></strong></p><p>-&nbsp;&nbsp;&nbsp; شفاء قرحات المعدة، أو قرحات الأمعاء (الإثنى عشر)</p><p>-&nbsp;&nbsp;&nbsp; الشفاء والوقاية من المشاكل الناجمة عن وجود الحمض في المريء أو فرط كمية الحمض في المعدة. كلاً من هذه الأسباب تسبب الشعور بالألم أو عدم الشعور بالراحة أحياناً يعرف &quot;بعسر الهضم&quot; أو &quot;حرقة المعدة&quot;</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p><strong>يجب عليك عدم استعمال رانتاج في الحالات التالية:</strong></p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حساسية تجاه رانيتيدين<strong> </strong>أو تجاه أياً من المواد الغير فعالة الأخرى التي يحتوي عليها هذا الدواء. (المذكورة في قسم 6)</p><p>يرجى منك التحدث مع طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل أن يتم إعطائك <strong>رانتاج</strong> إذا لم تكن متاكداً.</p><p><strong>تحذيرات واحتياطات</strong></p><p>يرجى منك استشارة طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل أن يتم إعطائك هذا الدواء في الحالات التالية:</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من سرطان المعدة</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من مشاكل في الكلى. سوف تكون بحاجة إلى جرعة مختلفة من <strong>رانتاج </strong></p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني مسبقاً من قرحات في المعدة</p><p>-&nbsp;&nbsp;&nbsp; إذا لديك تاريخ مرضي مسبق من مشاكل في القلب</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من حالة مرضية نادرة تعرف باسم البروفيريا الحادة</p><p>-&nbsp;&nbsp;&nbsp; إذا عمرك يتجاوز 65 عاماً</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أمراض الرئة</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من داء السكري</p><p>-&nbsp;&nbsp;&nbsp; إذا كنت تعاني من أية مشاكل في الجهاز المناعي</p><p>يرجى منك التحدث مع طبيبك المعالج أو الصيدلي الذي تتعامل معه قبل أن يتم إعطائك هذا الدواء، ما لم تكن متأكداً من مما ذكر أعلاه ينطبق عليك.</p><p><strong>تناول الأدوية الأخرى بالتزامن مع رانتاج</strong></p><p>يرجى منك اخبار &nbsp;طبيبك المعالج أو الصيدلي الذي تتعامل معه إذا كنت تتناول أو تناولت مؤخراً أو قد تتناول أية أدوية أخرى. بما في ذلك الأدوية التي تصرف بدون وصفة طبيبة والأعشاب الطبية. حيث أن <strong>رانتاج </strong>يؤثر على آلية عمل بعض الأدوية الأخرى. كما أن بعض الأدوية قد تؤثر على آلية عمل <strong>رانتاج</strong>.</p><p>&nbsp;يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه بصورة خاصة إذا كنت تتناول أياً من الأدوية التالية:</p><p>-&nbsp;&nbsp;&nbsp; ليدوكايين، وهو مخدر موضعي</p><p>-&nbsp;&nbsp;&nbsp; بروبرانولول، بروكيناميد أو إن- أسيتيل بروكيناميد، لعلاج مشاكل القلب</p><p>-&nbsp;&nbsp;&nbsp; ديازيبام، لعلاج مشاكل القلق</p><p>-&nbsp;&nbsp;&nbsp; الفينيتوين، لعلاج الصرع</p><p>-&nbsp;&nbsp;&nbsp; ثيوفيلين، لعلاج مشاكل التنفس (الربو)</p><p>-&nbsp;&nbsp;&nbsp; وارفارين لترقيق الدم</p><p>-&nbsp;&nbsp;&nbsp; جليبيزيد، لتقليل مستوى السكر في الدم</p><p>-&nbsp;&nbsp;&nbsp; اتازانافيرأو ديلافيريدين، لعلاج عدوى نقص المناعة البشرية المكتسبة</p><p>-&nbsp;&nbsp;&nbsp; ترايازولام، لعلاج الأرق</p><p>-&nbsp;&nbsp;&nbsp; جيفتنيب، لعلاج سرطان الرئة</p><p>-&nbsp;&nbsp;&nbsp; كيتوكونازول، وهو دواء مضاد للفطريات، يستخدم أحيانا لعلاج داء القلاع</p><p>ميدازولام هو دواء الذي قد يعطى لك فقط مباشرة قبل الخضوع للعمليات الجراحية. يرجى منك إخبار طبيبك المعالج قبل أن يتم إعطائك <strong>رانتاج</strong> في حال ما أراد طبيبك المعالج إعطائك ميدازولام.</p><p>يرجى منك التحدث إلى طبيبك المعالج أو الصيدلي الذى تتعامل معه أو الممرض ما لم تكن متأكداً مما ذكر أعلاه ينطبق عليك أن يتم إعطائك <strong>رانتاج</strong>.</p><p><strong>الحمل والرضاعة الطبيعية</strong></p><p>يجب عليك عدم استعمال هذا الدواء إذا كنت حاملاً، قد تصبحين حاملاً أو ترضعين طفلك رضاعة طبيعية، ما لم ينصحك طبيبك المعالج بضرورة استعماله.</p><p>يرجى منك استشارة طبيبك المعالج، الصيدلي الذي تتعاملين معه أو الممرض للحصول على النصيحة، إذا كنت حاملاً أو ترضعين طفلك رضاعة طبيعية.</p><p><strong>معلومات هامة حول بعض مكونات رانتاج</strong></p><p>تحتوي حقن <strong>رانتاج </strong>على الصوديوم ولذلك يجب اتباع حمية خالية من الصوديوم.</p><p>تحتوي حقن <strong>رانتاج </strong>على البوتاسيوم ولذلك يجب اتباع حمية خالية من البوتاسيوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>من غير المتوقع أن تستعمل هذا الدواء من تلقاء نفسك. سوف يتم إعطائك هذا الدواء دائماً عن طريق شخص مؤهل لفعل ذلك.</p><p><strong>استعمال هذا الدواء </strong></p><p>سوف يتم إعطائك حقنة <strong>رانتاج </strong>إما عن طريق:</p><p>-&nbsp;&nbsp;&nbsp; حقنة مفردة في العضل</p><p>-&nbsp;&nbsp;&nbsp; أو بالتسريب الوريدي البطيء. بحيث يتم إعطاء هذا الدواء ببطئ على مدى فترة زمنية لا تتعدى عدة دقائق.</p><p>-&nbsp;&nbsp;&nbsp; أو بالتسريب الوريدي المستمر. بحيث يتم إعطاء هذا الدواء ببطئ على مدى فترة زمنية لا تتعدى عدة ساعات.</p><p>يبلغ مقدار الجرعة الاعتيادية للبالغين (بما في ذلك فئة كبار السن) والمراهقين (12سنه وما فوق) 50 ملغم كل&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;6 إلى 8 ساعات، على هيئة حقنة مفردة في العضل.</p><p>كما قد يعطى لك جرعات مختلفة من حقن<strong> رانتاج</strong> عن طريق التسريب الوريدي البطيء أو المستمر، معتمداً على الحالة المرضية التي يعاني منها المريض.</p><p>&nbsp;</p><p><strong>الأطفال والرضع (بعمر يترواح من 6 شهورإلى 11 سنة</strong>)</p><p>سوف يتم إعطائك <strong>رانتاج</strong> عن طريق الحقن البطيء في الوريد من قبل طبيبك المعالج. يبلغ مقدار الجرعة القصوى</p><p>50 ملغم كل 6 إلى 8 ساعات. عادةً &nbsp;يعطى هذا الدواء فقط عندما يكون طفلك ليس لديه القدرة على تناول الدواء عن طريق الفم.</p><p><strong>إذا تم إعطائك </strong><strong>رانتاج</strong><strong> بجرعة أكبر مما يجب </strong></p><p>سوف يقوم طبيبك المعالج أو الممرض بإعطائك حقنة <strong>رانتاج</strong> لذلك من غير المحتمل أن تتلقى مقدار جرعة أكبر مما يجب. يرجى منك إخبار طبيبك المعالج أو الممرض إذا كنت تعتقد أنه تم إعطائك جرعة أكبر مما يجب أو سهوت عن أخذ الجرعة.<strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>شأنه شأن جميع الأدوية، قد يؤدي هذا الدواء إلى حدوث تأثيرات جانبية. على الرغم من ذلك قد لا تحدث &nbsp;لكل شخص</p><p>قد تحدث التأثيرات الجانبية التالية خلال فترة استعمال هذا الدواء</p><p><strong>يرجى منك عن التوقف استعمال رانتاج والتواصل مع طبيبك المعالج على الفور، إذا لاحظت أياً من التأثيرات الجانبية الخطيرة التالية، فقد تكون بحاجة إلى علاج طبي طارئ:</strong></p><p>&middot;&nbsp;&nbsp; التفاعلات التحسسية، قد تتضمن أعراض حدوث ذلك على:</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي، حكة أو طفح جلدي على شكل خلايا النحل</p><p>-&nbsp;&nbsp;&nbsp; تورم الوجه، الشفتين، اللسان أو أجزاء أخرى من الجسم</p><p>-&nbsp;&nbsp;&nbsp; ألم في الصدر، ضيق في التنفس، أزيزأو المعاناة من مشاكل بالتنفس</p><p>-&nbsp;&nbsp;&nbsp; حمى غير مبررة وشعور بالإغماء، وبصورة خاصة عند الوقوف</p><p>&middot;&nbsp;&nbsp; مشاكل في الكلى، والتي تؤدي إلى حدوث ألم في الظهر، حمى، ألم أثناء التبول، ظهور دم في البول وتغيرات في اختبارات الدم</p><p>&middot;&nbsp;&nbsp; ألم حاد في المعدة، والذي قد يكون علامة لحدوث حالة مرضية تعرف باسم &quot;التهاب البنكرياس&quot;</p><p>&middot;&nbsp;&nbsp; بطء أو عدم انتظام نبضات القلب</p><p>يرجى منك استشارة &nbsp;طبيبك المعالج في <strong>الزيارة المقبلة</strong> إذا لاحظت أياً من التالي:</p><p><strong>غير شائعة </strong>(تؤثر على ما يصل إلى&nbsp; شخص واحد من كل 100 شخص)</p><p>-&nbsp;&nbsp;&nbsp; ألم في المعدة</p><p>-&nbsp;&nbsp;&nbsp; إمساك</p><p>-&nbsp;&nbsp;&nbsp; الشعور بالإعياء (الغثيان)</p><p><strong>نادرة </strong>(تؤثر على ما يصل الى&nbsp; شخص واحد من كل 1000 شخص)</p><p>-&nbsp;&nbsp;&nbsp; طفح جلدي</p><p><strong>تأثيرات جانبية نادرة ممكن أن تظهر في اختبارات الدم:</strong></p><p>-&nbsp;&nbsp;&nbsp; زياده نسبة الكرياتينين في الدم (اختبارات وظائف الكلى<strong>)</strong></p><p>-&nbsp;&nbsp;&nbsp; تغيرات في وظائف الكبد</p><p>يرجى منك استشارة طبيبك المعالج في <strong>أسرع وقت ممكن</strong> إذا لاحظت أياً من التالي:</p><p><strong>نادر جداً </strong>(تؤثر على ما يصل إلى شخص واحد من كل 10000 شخص)</p><p>-&nbsp;&nbsp;&nbsp; قد يحدث تغيير في مستوى بعض المواد في الدم. من المحتمل أن يؤدي ذلك إلى الشعور بالتعب الغير معتاد أو ضيق في التنفس و تصبح أكثر عرضة لظهور الكدمات أو الإصابة بالعدوى</p><p>-&nbsp;&nbsp;&nbsp; الشعور بالاكتئاب، الارتباك، ورؤية أو سماع أشياء غير مبررة (هلوسة)</p><p>-&nbsp;&nbsp;&nbsp; صداع (شديد في بعض الأحيان)</p><p>-&nbsp;&nbsp;&nbsp; الشعور بالدوار أو عدم وضوح الرؤية</p><p>-&nbsp;&nbsp;&nbsp; ألم أو تورم&nbsp; في المفاصل أو العضلات أو عدم القدرة على السيطرة على حركتهم</p><p>-&nbsp;&nbsp;&nbsp; تورم الأوعية الدموية الصغيرة (تعرف باسم &quot;إلتهاب الأوعية الدموية&quot;). قد تتضمن أعراض حدوث ذلك على : طفح جلدي، تورم المفاصل أو مشاكل في الكلى</p><p>-&nbsp;&nbsp;&nbsp; تورم الكبد. مما قد يؤدي إلى: غثيان (الشعور بالإعياء) أو تقيؤ (توعك)، فقدان الشهية أو الشعور بعدم الراحة بصورة عامة، حكة، حمى، إصفرار الجلد والعينين أو بول داكن اللون</p><p>-&nbsp;&nbsp;&nbsp; تهيج أو ظهور علامات على الجلد</p><p>-&nbsp;&nbsp;&nbsp; سقوط الشعر الغير مبرر</p><p>-&nbsp;&nbsp;&nbsp; إسهال</p><p>-&nbsp;&nbsp;&nbsp; عجز جنسي</p><p>-&nbsp;&nbsp;&nbsp; ألم&nbsp; في الثدي أو/وتضخم الثدي</p><p>-&nbsp;&nbsp;&nbsp; خروج إفرازات من الثدي</p><p>-&nbsp;&nbsp;&nbsp; الشعور بنبضات القلب و/أو زيادة معدل نبضات القلب</p><p><strong>غير معروفة (لا يمكن تقدير معدل تكرار حدوثها من البيانات المتاحة</strong><strong>(</strong></p><p>-&nbsp;&nbsp;&nbsp; ضيق في التنفس</p><p><strong>&nbsp;يرجى منك إخبار طبيبك المعالج أو الصيدلي الذي تتعامل معه، إذا زادت حدة أياً من التأثيرات الجانبية، أو في </strong><strong>حال ملاحظة حدوث أية تأثيرات جانبية </strong><strong>لم تذكر في هذه النشرة</strong>.</p><p><strong><u>للإبلاغ عن حدوث أية تأثيرات جانبية:</u></strong><br /><strong>المركز الوطني للتيقظ والسلامة الدوائية</strong></p><p><strong>رقم الفاكس: </strong>7662-205-11-966+</p><p><strong>يرجى الاتصال بالمركز الوطني للتيقظ والسلامة الدوائية على: </strong>2038222-11-966+&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p><strong>تحويلة هاتف:</strong>2340-2334-2354-2353-2356-2317</p><p><strong>الهاتف المجاني: </strong>8002490000</p><p><strong>البريد الإلكتروني:</strong><strong> </strong>&nbsp;npc.drug@sfda.gov.sa</p><p><strong>الموقع الإلكتروني:</strong> www.sfda.gov.sa/npc</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>-&nbsp;&nbsp;&nbsp; يحفظ بعيداً عن متناول ومرأى الأطفال.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم استعمال <strong>رانتاج </strong>بعد تاريخ انتهاء الصلاحية المذكور على العلبة والملصق الداخلي.</p><p>-&nbsp;&nbsp;&nbsp; احفظ الدواء في درجة حرارة أقل من 30&ordm;م. بعيداً عن الضوء والحرارة.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم استعمال <strong>رانتاج </strong>إذا لاحظت وجود&nbsp; أي علامات تلف واضحة.</p><p>-&nbsp;&nbsp;&nbsp; يجب عدم التخلص من الأدوية عبر المياه المبتذلة (مياه الصرف الصحي) أو النفايات المنزلية. اسأل الصيدلي الذي تتعامل معه عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي رانيتيدين. تحتوي كل أمبولة (2 ملليلتر) على 50 ملغم من رانيتيدين&nbsp; (على هيئة هيدروكلوريد).</p><p>المواد غير الفعالة: فوسفات الصوديوم ثنائي القاعدة ، فوسفات البوتاسيوم آحادي القاعدة، فينول، وماء معد للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            تتوفر أمبولات رانتاج في عبوات تحتوي كلاً منها على  5 أمبولات أو50 أمبولة (سعة الأمبولة  2ملليلتر).
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>&quot;الخليج للصناعات الدوائية &quot; جلفار</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            
09/03/2015

        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Rantag 50mg/2mL Solution for Injection 
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each ampoule (2mL) contains: 
Item No. 	Material Name	Scale (mg/2mL)
		
	Active Ingredient:	
1.		Ranitidine 	50.000
	Use: Ranitidine Hydrochloride	56.000
		
	Inactive Ingredients:	
1.		Sodium phosphate dibasic 	4.800
2.		Potassium phosphate monobasic 	1.920
3.		Phenol 	10.000
4.		Water for injection	q.s. to 2 mL

For a full list of excipients, see section 6.1.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution for injection
Description: A clear, colorless to faint yellow solution.


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Adults:</u></strong></p><p><strong>Rantag</strong> Injection is indicated for the treatment of duodenal ulcer, benign gastric ulcer, post - operative ulcer, reflux oesophagitis, Zollinger - Ellison Syndrome and the following conditions where reduction of gastric secretion and acid output is desirable:</p><p>The prophylaxis of gastrointestinal haemorrhage from stress ulceration in seriously ill patients, the prophylaxis of recurrent haemorrhage in patients with bleeding peptic ulcers and before general anaesthesia in patients considered to be at risk of acid aspiration (Mendelson&#39;s Syndrome), particularly obstetric patients during labour. For appropriate cases, <strong>Rantag</strong> tablets are also available.</p><p><strong><u>Children (6 months to 18 years):</u></strong></p><p><strong>Rantag</strong> Injection is indicated for the short term treatment of peptic ulcer and the treatment of gastro-oesophageal reflux, including reflux oesophagitis and symptomatic relief of gastro-oesophageal reflux disease.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>(See section 5.2 Pharmacokinetic properties &ndash; Other special - populations)</p><p><strong><u>Posology</u></strong></p><p><strong><u>Adults (including elderly) / Adolescents (12 years and over)</u></strong></p><p><strong>Rantag</strong> Injection may be given either as a slow (over 2 minutes) intravenous injection up to a maximum of 50 mg, after dilution to a volume of 20 ml per 50 mg dose, which may be repeated every 6 to 8 hours; or as an intermittent intravenous infusion at a rate of 25 mg per hour for two hours; the infusion may be repeated at 6 to 8 hour intervals, or as an intramuscular injection of 50 mg (2 ml) every 6 to 8 hours.</p><p><strong>Prophylaxis of haemorrhage from stress ulceration or recurrent haemorrhage:</strong></p><p>In the prophylaxis of haemorrhage from stress ulceration in seriously ill patients or the prophylaxis of recurrent haemorrhage in patients bleeding from peptic ulceration, parenteral administration may be continued until oral feeding commences. Patients considered to be still at risk may then be treated with <strong>Rantag </strong>tablets 150 mg twice daily.</p><p>In the prophylaxis of upper gastro-intestinal haemorrhage from stress ulceration in seriously ill patients a priming dose of 50 mg as a slow intravenous injection followed by a continuous intravenous infusion of 0.125 - 0.250 mg/kg/hr may be preferred.</p><p><strong>Prophylaxis of Mendleson&#39;s syndrome:</strong></p><p>In patients considered to be at risk of developing acid aspiration syndrome, ranitidine Injection 50 mg may be given intramuscularly or by slow intravenous injection 45 to 60 minutes before induction of general anaesthesia.</p><p><strong><u>Children / Infants (6 months to 11 years)</u></strong></p><p>(See section 5.2 Pharmacokinetic properties) &ndash; Other special populations</p><p><strong>Rantag</strong> injection may be given as a slow (over 2 minutes) i.v. injection up to a maximum of 50 mg every 6 to 8 hours.</p><p><strong>Peptic Ulcer Acute Treatment and Gastro-Oesophageal Reflux</strong></p><p>Intravenous therapy in children with peptic ulcer disease is indicated only when oral therapy is not possible.</p><p>For acute treatment of peptic ulcer disease and gastro-oesophageal reflux in paediatric patients, ranitidine injection may be administered at doses that have been shown to be effective for these diseases in adults and effective for acid suppression in critically ill children. The initial dose (2.0 mg/kg or 2.5 mg/kg, maximum 50 mg) may be administered as a slow intravenous infusion over 10 minutes, either with a syringe pump followed by a 3 mL flush with normal saline over 5 min, or following dilution with normal saline to 20 mL. Maintenance of pH &gt; 4.0 can be achieved by intermittent infusion of 1.5 mg/kg every 6 h to 8 h. Alternatively treatment can be continuous, administering a loading dose of 0.45 mg/kg followed by a continuous infusion of 0.15 mg/kg/hr.</p><p><strong><u>Neonates (under 1 month)</u></strong></p><p>(See section 5.2 &ndash; Pharmacokinetic properties &ndash; Other special populations)</p><p><strong><u>Patients over 50 years of age</u></strong></p><p>See section 5.2 Pharmacokinetic properties - Other special populations</p><p><strong><u>Patients with renal impairment</u></strong></p><p>Accumulation of ranitidine with resulting elevated plasma concentrations will occur in patients with renal impairment (creatinine clearance less than 50 ml/min). Accordingly, it is recommended in such patients that ranitidine be administered in doses of 25 mg.</p><p><strong><u>Method of administration</u></strong></p><p>Intravenous or intramuscular injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Malignancy</u></strong></p><p>The possibility of malignancy should be excluded before commencement of therapy in patients with gastric ulcer as treatment with ranitidine may mask symptoms of gastric carcinoma.</p><p><strong><u>Renal Disease</u></strong></p><p>Ranitidine is excreted via the kidney and so plasma levels of the drug are increased in patients with renal impairment. The dosage should be adjusted as detailed in section 4.2 Patients with renal impairment.</p><p>Bradycardia in association with rapid administration of ranitidine injection has been reported rarely, usually in patients with factors predisposing to cardiac rhythm disturbances. Recommended rates of administration should not be exceeded.</p><p>It has been reported that the use of higher than recommended doses of intravenous H<sub>2</sub>-antagonists has been associated with rises in liver enzymes when treatment has been extended beyond five days.</p><p>Rare clinical reports suggest that ranitidine may precipitate acute porphyric attacks. Ranitidine should therefore be avoided in patients with a history of acute porphyria.</p><p>In patients such as the elderly, persons with chronic lung disease, diabetes or the immunocompromised, there may be an increased risk of developing community acquired pneumonia. A large epidemiological study showed an increased risk of developing community acquired pneumonia in current users of ranitidine alone versus those who had stopped treatment, with an observed adjusted relative risk increase of 1.82 (95% CI 1.26-2.64).. Post-marketing data indicate reversible mental confusion, depression, and hallucinations have been reported most frequently in severely ill and elderly patients (see section 4.8).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Ranitidine has the potential to affect the absorption, metabolism or renal excretion of other drugs. The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment</p><p><strong><u>Interactions occur by several mechanisms including:</u></strong></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Inhibition of cytochrome P450-linked mixed function oxygenase system: </strong></p><p>Ranitidine at usual therapeutic doses does not potentiate the actions of drugs which are inactivated by this enzyme system such as diazepam, lidocaine, phenytoin, propanolol and theophylline.</p><p>There have been reports of altered prothrombin time with coumarin anticoagulants (e.g. warfarin). Due to the narrow therapeutic index, close monitoring of increased or decreased prothrombin time is recommended during concurrent treatment with ranitidine.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Competition for renal tubular secretion:</strong></p><p>Since ranitidine is partially eliminated by the cationic system, it may affect the clearance of other drugs eliminated by this route. High doses of ranitidine (e.g. such as those used in the treatment of Zollinger-Ellison syndrome) may reduce the excretion of procainamide and N-acetylprocainamide resulting in increased plasma level of these drugs.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <strong>Alteration of gastric pH:</strong></p><p>The bioavailability of certain drugs may be affected. This can result in either an increase in absorption (e.g. triazolam, midazolam, glipizide) or a decrease in absorption (e.g. ketoconazole, atazanavir, delaviridine, gefitnib).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Pregnancy</u></strong></p><p>Ranitidine crosses the placenta but therapeutic doses administered to obstetric patients in labour or undergoing caesarean section have been without any adverse effect on labour, delivery or subsequent neonatal progress. Like other drugs, ranitidine should only be used during pregnancy if considered essential.</p><p><strong><u>Breast-feeding</u></strong></p><p>ranitidine is also excreted in human breast milk. Like other drugs, ranitidine should only be used during breast-feeding if considered essential.</p><p><strong><u>Fertility</u></strong></p><p>There are no data on the effects of ranitidine on human fertility. There were no effects on male and female fertility in animal studies (see section 5.3).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None reported.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The following convention has been utilised for the classification of undesirable effects: very common (&ge;1/10), common (&ge;1/100, &lt;1/10), uncommon (&ge;1/1000, &le;1/100), rare (&ge;1/10,000, &le;1/1000), very rare (&le;1/10,000). Adverse event frequencies have been estimated from spontaneous reports from post-marketing data.</p><table border="0" cellspacing="0" cellpadding="0" style="width:730px"><tbody><tr><td colspan="2" style="vertical-align:top"><p><strong>Blood &amp; Lymphatic System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Blood count changes (leucopenia, thrombocytopenia). These are usually reversible. Agranulocytosis or pancytopenia, sometimes with marrow hypoplasia or marrow aplasia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Immune System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Hypersensitivity reactions (urticaria, angioneurotic oedema, fever, bronchospasm, hypotension and chest pain).</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Anaphylactic shock.</p></td></tr><tr><td style="vertical-align:top"><p>Not known:</p></td><td style="vertical-align:top"><p>Dyspnoea</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>These events have been reported after a single dose.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Psychiatric Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Reversible mental confusion, depression and hallucinations.</p><p>These have been reported predominantly in severely ill patients, in elderly and nephropatic patients.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Nervous System Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Headache (sometimes severe), dizziness and reversible involuntary movement disorders.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Eye Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Reversible blurred vision.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p>There have been reports of blurred vision, which is suggestive of a change in accommodation.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Cardiac Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>As with other H<sub>2</sub>&nbsp;receptor antagonists bradycardia, A-V block, asystole and tachycardia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Vascular Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Vasculitis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Gastrointestinal Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Uncommon:</p></td><td style="vertical-align:top"><p>Abdominal pain, constipation, nausea (these symptoms mostly improved during continued treatment).</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Acute pancreatitis, diarrhoea.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Hepatobiliary Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Transient and reversible changes in liver function tests.</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Hepatitis (hepatocellular, hepatocanalicular or mixed) with or without jaundice, these were usually reversible.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Skin and Subcutaneous Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Skin Rash.</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Erythema multiforme, alopecia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Musculoskeletal and Connective Tissue Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Musculoskeletal symptoms such as arthralgia and myalgia.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Renal and Urinary Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Rare:</p></td><td style="vertical-align:top"><p>Elevation of plasma creatinine (usually slight; normalised during continued treatment)</p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Acute interstitial nephritis.</p></td></tr><tr><td colspan="2" style="vertical-align:top"><p><strong>Reproductive System and Breast Disorders</strong></p></td></tr><tr><td style="vertical-align:top"><p>Very Rare:</p></td><td style="vertical-align:top"><p>Reversible impotence, breast symptoms and breast conditions (such as gynaecomastia and galactorrhoea).</p></td></tr></tbody></table><p><strong>Paediatric population</strong></p><p>The safety of ranitidine has been assessed in children aged 0 to 16 years with acid-related disease and was generally well tolerated with an adverse event profile resembling that in adults. There are limited long term safety data available, in particular regarding growth and development.</p><p><strong><em><u>&nbsp;</u></em></strong></p><p><strong><em><u>To report any side effect(s)</u></em></strong><strong><em><u>:</u></em></strong><strong><em><u> </u></em></strong></p><p><strong>The National Pharmacovigilance and Drug Safety Centre (NPC)</strong></p><p><strong>Fax:</strong> +966-11-205-7662</p><p><strong>Call NPC at</strong> +966-11-2038222, <strong>Exts:</strong> 2317-2356-2353-2354-2334-2340.</p><p><strong>Toll free phone:</strong> 8002490000</p><p><strong>E-mail:</strong> npc.drug@sfda.gov.sa</p><p><strong>Website:</strong> www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Symptoms and signs</u></strong></p><p>Ranitidine is very specific in action and accordingly, no particular problems are expected following overdosage with the drug.</p><p><strong><u>Treatment</u></strong></p><p>Symptomatic and supportive therapy should be given as appropriate.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Pharmacotherapeutic group:</strong> H2-receptor antagonists</p><p><strong>ATC code:</strong> A02BA02</p><p><strong>Mechanism of action</strong></p><p>Ranitidine is a specific, rapidly acting histamine H<sub>2</sub>-antagonist. It inhibits basal and stimulated secretion of gastric acid, reducing both the volume and the acid and pepsin content of the secretion.</p><p>The clinical data available mentions the use of ranitidine in children to prevent stress ulcers. No direct evidence for prevention of stress ulcers is available. Treatment for these patients is based on the observation that pH is above 4 after administration of ranitidine. The value of this surrogate parameter in children with stress ulcers remains to be established.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Absorption</u></strong></p><p>Absorption of ranitidine after intramuscular injection is rapid and peak plasma concentrations are usually achieved within 15 minutes of administration.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong><u>Distribution</u></strong></p><p>Ranitidine is not extensively bound to plasma proteins (15%), but exhibits a large volume of distribution ranging from 96 to 142 L.</p><p><strong><u>Metabolism</u></strong></p><p>Ranitidine is not extensively metabolised. The fraction of the dose recovered as metabolites is similar after both oral and i.v. dosing; and includes 6% of the dose in urine as the N-oxide, 2&amp; as the S-oxide, 2% as desmethylranitidine and 1 to 2% as the furoic acid analogue.</p><p><strong><u>Elimination</u></strong></p><p>Plasma concentrations decline bi-exponentially, with a terminal half-life of 2-3 hours. The major route of elimination is renal. After IV administration of 150 mg 3H-ranitidine, 98% of the dose was recovered, including 5% in faeces and 93% in urine, of which 70% was unchanged parent drug. After oral administration of 150 mg 3H-ranitidine, 96% of the dose was recovered, 26% in faeces and 70% in urine of which 35% was unchanged parent drug. Less than 3% of the dose is excreted in bile. Renal clearance is approximately 500 mL/min, which exceeds glomerular filtration indicating net renal tubular secretion.</p><p><strong><u>Other special populations</u></strong></p><p><strong>Children/infants (6 months and above)</strong></p><p>Limited pharmacokinetic data show that there were no significant differences in half-life (range for children 3 years and above: 1.7 - 2.2 h) and plasma clearance (range for children 3 years and above: 9 - 22 ml/min/kg) between children and healthy adults receiving intravenous ranitidine when correction is made for body weight. Pharmacokinetic data in infants is extremely limited but appears to be in line with that for older children.</p><p><strong>Patients over 50 years of age</strong></p><p>In patients over 50 years of age, half-life is prolonged (3-4 h) and clearance is reduced, consistent with the age-related decline of renal function. However, systemic exposure and accumulation are 50% higher. This difference exceeds the effect of declining renal function, and indicates increased bioavailability in older patients.</p><p><strong>Neonates (under 1 month)</strong></p><p>Limited pharmacokinetic data from term babies undergoing treatment with Extracorporeal Membrane Oxygenation (EMCO) suggests that plasma clearance following iv administration may be reduced (1.5-8.2 ml/min/kg) and the half-life increased in the new-born. Clearance of ranitidine appeared to be related to the estimated glomerular filtration rate in the neonates.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Non-clinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated-dose toxicity, genotoxicity, carcinogenic potential and toxicity to reproduction and development.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong><u>Inactive Ingredients</u></strong></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sodium phosphate dibasic</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Potassium phosphate monobasic</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Phenol</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Water for injection</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>This medicinal product must not be mixed with other medicinal products except those mentioned in section 6.6.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                24 months from the date of manufacturing.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C. Protect from light and heat.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&sect; 5 Labelled ampoules (2ml, glass ampoule, type 1, USP) in a tray, packed in a printed box along with a leaflet.</p><p>&sect; 50 Labelled ampoules (2ml, glass ampoule, type 1, USP) packed in a printed box using honey comb partition along with a leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Rantag</strong> Injection has been shown to be compatible with the following intravenous infusion fluids:</p><p>&sect; 0.9% Sodium Chloride BP</p><p>&sect; 5% Dextrose BP</p><p>&sect; 0.18% Sodium Chloride and 4% Dextrose BP</p><p>&sect; 4.2% Sodium Bicarbonate BP</p><p>&sect; Hartmann&#39;s Solution.</p><p>All unused mixtures of <strong>Rantag</strong> Injection with infusion fluids should be discarded 24 hours after preparation.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Gulf Pharmaceutical Industries - Julphar
Digdaga, Airport Street.
Ras Al Khaimah - United Arab Emirates.
P.O. Box 997
Tel. No.: (9717) 2 461 461
Fax No.: (9717) 2 462 462


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                15. June. 2016
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>